CG Oncology (CGON) Change in Inventory (2025 - 2026)

CG Oncology (CGON) reported Change in Inventory of -$72000.0 for Q1 2026, down 212.5% quarter-over-quarter from $64000.0 in Q4 2025.

CG Oncology (CGON) Change in Inventory (2025 - 2026) Analysis & Trends

CG Oncology has reported Change in Inventory for 2 years, with the latest figure at -$72000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	51,468.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	97.70 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	CG Oncology	5.16 Bn	5.16 Bn	-1.88 Mn	-72,000.00

Download Data